RecruitingNCT07388966

Prospective Longitudinal Monocentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia

Prospective Longitudinal Monocentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia Using Syde®

Sponsor

SYSNAV

Enrollment

40 participants

Start Date

Feb 6, 2026

Study Type

OBSERVATIONAL

Conditions

Achondroplasia Hypochondroplasia

Summary

The study aims to identify which Syde®-derived digital outcomes are reliable in FGFR3-related Skeletal Dysplasia. This requires to set-up a natural history study to measure limb movements in patients with ACH or HCH.

Eligibility

Min Age: 3 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with achondroplasia and hypochondroplasia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.